{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:24:22Z","timestamp":1792679062269,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273195"],"award-info":[{"award-number":["82273195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874083"],"award-info":[{"award-number":["81874083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072776"],"award-info":[{"award-number":["82072776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273286"],"award-info":[{"award-number":["82273286"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072775"],"award-info":[{"award-number":["82072775"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203419"],"award-info":[{"award-number":["82203419"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Intratumoral heterogeneity is the primary challenge in the treatment of glioblastoma (GBM). The presence of glioma stem cells (GSCs) and their conversion between different molecular phenotypes contribute to the complexity of heterogeneity, culminating in preferential resistance to radiotherapy. ARP2\/3 (actin-related protein-2\/3) complexes (ARPs) are associated with cancer migration, invasion and differentiation, while the implications of ARPs in the phenotype and resistance to radiotherapy of GSCs remain unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We screened the expression of ARPs in TCGA-GBM and CGGA-GBM\u00a0databases. Tumor sphere formation assays and limiting dilution assays were applied to assess the implications of ARPC1B in tumorigenesis. Apoptosis, comet, \u03b3-H2AX immunofluorescence (IF), and cell cycle distribution assays were used to evaluate the effect of ARPC1B on radiotherapy resistance. Immunoprecipitation (IP) and mass spectrometry analysis were used to detect ARPC1B-interacting proteins. Immune blot assays were performed to evaluate protein ubiquitination, and deletion mutant constructs were designed to determine the binding sites of protein interactions. The Spearman correlation algorithm was performed to screen for drugs that indicated cell sensitivity by the expression of ARPC1B. An intracranial xenograft GSC mouse model was used to investigate the role of ARPC1B in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We concluded that ARPC1B was significantly upregulated in MES-GBM\/GSCs and was correlated with a poor prognosis. Both in vitro and in vivo assays indicated that knockdown of ARPC1B in MES-GSCs reduced tumorigenicity and resistance to IR treatment, whereas overexpression of ARPC1B in PN-GSCs exhibited the opposite effects. Mechanistically, ARPC1B interacted with IFI16 and HuR to maintain protein stability. In detail, the Pyrin of IFI16 and RRM2 of HuR were implicated in binding to ARPC1B, which counteracted TRIM21-mediated degradation of ubiquitination to IFI16 and HuR. Additionally, the function of ARPC1B was dependent on IFI16-induced activation of NF-\u03baB pathway and HuR-induced activation of STAT3 pathway. Finally, we screened AZD6738, an ataxia telangiectasia mutated and rad3-related (ATR) inhibitor, based on the expression of ARPC1B. In addition to ARPC1B expression reflecting cellular sensitivity to AZD6738, the combination of AZD6738 and radiotherapy exhibited potent antitumor effects both in vitro and in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>ARPC1B promoted MES phenotype maintenance and radiotherapy resistance by inhibiting TRIM21-mediated degradation of IFI16 and HuR, thereby activating the NF-\u03baB and STAT3 signaling pathways, respectively. AZD6738, identified based on ARPC1B expression, exhibited excellent anti-GSC activity in combination with radiotherapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-022-02526-8","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T03:03:50Z","timestamp":1668567830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells"],"prefix":"10.1186","volume":"41","author":[{"given":"Zijie","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongpu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"issue":"8","key":"2526_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"D Louis","year":"2021","unstructured":"Louis D, Perry A, Wesseling P, Brat D, Cree I, Figarella-Branger D, Hawkins C, Ng H, Pfister S, Reifenberger G, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231\u201351.","journal-title":"Neuro Oncol"},{"issue":"7","key":"2526_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nrclinonc.2016.204","volume":"14","author":"G Reifenberger","year":"2017","unstructured":"Reifenberger G, Wirsching HG, Knobbe-Thomsen CB, Weller M. Advances in the molecular genetics of gliomas - implications for classification and therapy. Nat Rev Clin Oncol. 2017;14(7):434\u201352.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"2526_CR3","first-page":"54","volume":"4","author":"D Khosla","year":"2016","unstructured":"Khosla D. Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma. Ann Transl Med. 2016;4(3):54.","journal-title":"Ann Transl Med"},{"issue":"3","key":"2526_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1124\/pr.117.014944","volume":"70","author":"A Shergalis","year":"2018","unstructured":"Shergalis A, Bankhead A, Luesakul U, Muangsin N, Neamati N. Current Challenges and Opportunities in Treating Glioblastoma. Pharmacol Rev. 2018;70(3):412\u201345.","journal-title":"Pharmacol Rev"},{"issue":"4","key":"2526_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM, et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell. 2019;178(4):835-849 e821.","journal-title":"Cell"},{"issue":"1","key":"2526_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"R Verhaak","year":"2010","unstructured":"Verhaak R, Hoadley K, Purdom E, Wang V, Qi Y, Wilkerson M, Miller C, Ding L, Golub T, Mesirov J, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98\u2013110.","journal-title":"Cancer Cell"},{"issue":"1","key":"2526_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13046-020-01553-7","volume":"39","author":"J Xu","year":"2020","unstructured":"Xu J, Zhang Z, Qian M, Wang S, Qiu W, Chen Z, Sun Z, Xiong Y, Wang C, Sun X, et al. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-\u03baB activation. J Exp Clin Cancer Res. 2020;39(1):59.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"2526_CR8","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.celrep.2019.01.076","volume":"26","author":"M Minata","year":"2019","unstructured":"Minata M, Audia A, Shi J, Lu S, Bernstock J, Pavlyukov M, Das A, Kim S, Shin Y, Lee Y, et al. Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation. Cell Rep. 2019;26(7):1893-1905.e1897.","journal-title":"Cell Rep"},{"issue":"11","key":"2526_CR9","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/j.celrep.2016.11.056","volume":"17","author":"A Segerman","year":"2016","unstructured":"Segerman A, Niklasson M, Haglund C, Bergstrom T, Jarvius M, Xie Y, Westermark A, Sonmez D, Hermansson A, Kastemar M, et al. Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition. Cell Rep. 2016;17(11):2994\u20133009.","journal-title":"Cell Rep"},{"issue":"1","key":"2526_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/neuonc\/noz195","volume":"22","author":"M Platten","year":"2020","unstructured":"Platten M. Driving mesenchymal transition in glioblastoma. Neuro Oncol. 2020;22(1):1\u20132.","journal-title":"Neuro Oncol"},{"issue":"7120","key":"2526_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon R, Hao Y, Shi Q, Hjelmeland A, Dewhirst M, Bigner D, Rich J. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120):756\u201360.","journal-title":"Nature"},{"issue":"7412","key":"2526_CR12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen J, Li Y, Yu T, McKay R, Burns D, Kernie S, Parada L. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488(7412):522\u20136.","journal-title":"Nature"},{"issue":"9","key":"2526_CR13","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41418-018-0248-7","volume":"26","author":"A Narayanan","year":"2019","unstructured":"Narayanan A, Gagliardi F, Gallotti A, Mazzoleni S, Cominelli M, Fagnocchi L, Pala M, Piras I, Zordan P, Moretta N, et al. The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1. Cell Death Differ. 2019;26(9):1813\u201331.","journal-title":"Cell Death Differ"},{"issue":"8","key":"2526_CR14","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s41388-020-01635-y","volume":"40","author":"Z Wang","year":"2021","unstructured":"Wang Z, Shi Y, Ying C, Jiang Y, Hu J. Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-kappaB signaling. Oncogene. 2021;40(8):1458\u201375.","journal-title":"Oncogene"},{"issue":"7279","key":"2526_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature08712","volume":"463","author":"M Carro","year":"2010","unstructured":"Carro M, Lim W, Alvarez M, Bollo R, Zhao X, Snyder E, Sulman E, Anne S, Doetsch F, Colman H, et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2010;463(7279):318\u201325.","journal-title":"Nature"},{"issue":"3","key":"2526_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","volume":"24","author":"K Bhat","year":"2013","unstructured":"Bhat K, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James J, Goodman L, et al. Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma. Cancer Cell. 2013;24(3):331\u201346.","journal-title":"Cancer Cell"},{"issue":"24","key":"2526_CR17","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1101\/gad.176800.111","volume":"25","author":"K Bhat","year":"2011","unstructured":"Bhat K, Salazar K, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, James J, Gumin J, Diefes K, Kim S, et al. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev. 2011;25(24):2594\u2013609.","journal-title":"Genes Dev"},{"issue":"6","key":"2526_CR18","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ccell.2021.05.002","volume":"39","author":"T Hara","year":"2021","unstructured":"Hara T, Chanoch-Myers R, Mathewson N, Myskiw C, Atta L, Bussema L, Eichhorn S, Greenwald A, Kinker G, Rodman C, et al. Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma. Cancer Cell. 2021;39(6):779-792.e711.","journal-title":"Cancer Cell"},{"issue":"7","key":"2526_CR19","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1158\/2326-6066.CIR-19-0759","volume":"8","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Xu J, Chen Z, Wang H, Xue H, Yang C, Guo Q, Qi Y, Guo X, Qian M, et al. Transfer of MicroRNA via Macrophage-Derived Extracellular Vesicles Promotes Proneural-to-Mesenchymal Transition in Glioma Stem Cells. Cancer Immunol Res. 2020;8(7):966\u201381.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"2526_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13046-020-01807-4","volume":"40","author":"Z Chen","year":"2021","unstructured":"Chen Z, Wang H, Zhang Z, Xu J, Qi Y, Xue H, Gao Z, Zhao R, Wang S, Zhang S, et al. Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells. J Exp Clin Cancer Res. 2021;40(1):20.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2526_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrm3492","volume":"14","author":"J Rotty","year":"2013","unstructured":"Rotty J, Wu C, Bear J. New insights into the regulation and cellular functions of the ARP2\/3 complex. Nat Rev Mol Cell Biol. 2013;14(1):7\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"2526_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrm2026","volume":"7","author":"E Goley","year":"2006","unstructured":"Goley E, Welch M. The ARP2\/3 complex: an actin nucleator comes of age. Nat Rev Mol Cell Biol. 2006;7(10):713\u201326.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2526_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1152\/physrev.00006.2017","volume":"98","author":"N Molinie","year":"2018","unstructured":"Molinie N, Gautreau A. The Arp2\/3 Regulatory System and Its Deregulation in Cancer. Physiol Rev. 2018;98(1):215\u201338.","journal-title":"Physiol Rev"},{"issue":"2","key":"2526_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1158\/0008-5472.CAN-16-2060","volume":"77","author":"K Kazazian","year":"2017","unstructured":"Kazazian K, Go C, Wu H, Brashavitskaya O, Xu R, Dennis J, Gingras A, Swallow C. Plk4 Promotes Cancer Invasion and Metastasis through Arp2\/3 Complex Regulation of the Actin Cytoskeleton. Cancer Res. 2017;77(2):434\u201347.","journal-title":"Cancer Res"},{"issue":"6","key":"2526_CR25","first-page":"3189","volume":"41","author":"Z Cheng","year":"2019","unstructured":"Cheng Z, Wei W, Wu Z, Wang J, Ding X, Sheng Y, Han Y, Wu Q. ARPC2 promotes breast cancer proliferation and metastasis. Oncol Rep. 2019;41(6):3189\u2013200.","journal-title":"Oncol Rep"},{"issue":"12","key":"2526_CR26","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1111\/cas.14205","volume":"110","author":"J Choi","year":"2019","unstructured":"Choi J, Lee Y, Yoon Y, Kim C, Park S, Kim S, Doo Kim N, Cho Han D, Kwon B. Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2\/3 complex. Cancer Sci. 2019;110(12):3788\u2013801.","journal-title":"Cancer Sci"},{"key":"2526_CR27","doi-asserted-by":"publisher","first-page":"630147","DOI":"10.3389\/fcell.2020.630147","volume":"8","author":"J Mondaca","year":"2020","unstructured":"Mondaca J, Uzair I, Castro Guijarro A, Flamini M, Sanchez A. Molecular Basis of LH Action on Breast Cancer Cell Migration and Invasion via Kinase and Scaffold Proteins. Front Cell Dev Biol. 2020;8:630147.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2526_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.gendis.2021.02.012","volume":"9","author":"Z Wei","year":"2022","unstructured":"Wei Z, Wang R, Yin X, Zhang L, Lei Y, Zhang Y, Li Y, Wu J, Bu Y, Jin G, et al. PRR11 induces filopodia formation and promotes cell motility via recruiting ARP2\/3 complex in non-small cell lung cancer cells. Genes Dis. 2022;9(1):230\u201344.","journal-title":"Genes Dis"},{"issue":"11","key":"2526_CR29","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/nm.4197","volume":"22","author":"S Frentzas","year":"2016","unstructured":"Frentzas S, Simoneau E, Bridgeman V, Vermeulen P, Foo S, Kostaras E, Nathan M, Wotherspoon A, Gao Z, Shi Y, et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med. 2016;22(11):1294\u2013302.","journal-title":"Nat Med"},{"issue":"1","key":"2526_CR30","doi-asserted-by":"publisher","first-page":"2031499","DOI":"10.1080\/2162402X.2022.2031499","volume":"11","author":"T Liu","year":"2022","unstructured":"Liu T, Zhu C, Chen X, Wu J, Guan G, Zou C, Shen S, Chen L, Cheng P, Cheng W, et al. Dual role of ARPC1B in regulating the network between tumor-associated macrophages and tumor cells in glioblastoma. Oncoimmunology. 2022;11(1):2031499.","journal-title":"Oncoimmunology"},{"key":"2526_CR31","doi-asserted-by":"publisher","first-page":"736187","DOI":"10.3389\/fgene.2021.736187","volume":"12","author":"H Ji","year":"2021","unstructured":"Ji H, Zhao H, Jin J, Liu Z, Gao X, Wang F, Dong J, Yan X, Zhang J, Wang N, et al. Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma. Front Genet. 2021;12:736187.","journal-title":"Front Genet"},{"key":"2526_CR32","doi-asserted-by":"publisher","first-page":"738068","DOI":"10.3389\/fimmu.2021.738068","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Lu J, Li W. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma. Front Immunol. 2021;12:738068.","journal-title":"Front Immunol"},{"issue":"8","key":"2526_CR33","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm2450","volume":"9","author":"K Cimprich","year":"2008","unstructured":"Cimprich K, Cortez D. ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol. 2008;9(8):616\u201327.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2526_CR34","doi-asserted-by":"crossref","unstructured":"Forment J, O\u2019Connor M. Targeting the replication stress response in cancer. Pharmacol Ther. 2018;188:155\u201367.","DOI":"10.1016\/j.pharmthera.2018.03.005"},{"issue":"4","key":"2526_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3892\/or.2022.8289","volume":"47","author":"T Suzuki","year":"2022","unstructured":"Suzuki T, Hirokawa T, Maeda A, Harata S, Watanabe K, Yanagita T, Ushigome H, Nakai N, Maeda Y, Shiga K, et al. ATR inhibitor AZD6738 increases the sensitivity of colorectal cancer cells to 5-fluorouracil by inhibiting repair of DNA damage. Oncol Rep. 2022;47(4):78.","journal-title":"Oncol Rep"},{"issue":"3","key":"2526_CR36","doi-asserted-by":"publisher","first-page":"e004306","DOI":"10.1136\/jitc-2021-004306","volume":"10","author":"EC Patin","year":"2022","unstructured":"Patin EC, Dillon MT, Nenclares P, Grove L, Soliman H, Leslie I, Northcote D, Bozhanova G, Crespo-Rodriguez E, Baldock H, et al. Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade. J Immunother Cancer. 2022;10(3):e004306.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"2526_CR37","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.21037\/tlcr-21-437","volume":"10","author":"K Kundu","year":"2021","unstructured":"Kundu K, Cardnell RJ, Zhang B, Shen L, Stewart CA, Ramkumar K, Cargill KR, Wang J, Gay CM, Byers LA. SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer. Transl Lung Cancer Res. 2021;10(11):4095\u2013105.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"2526_CR38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13046-020-01582-2","volume":"39","author":"SL George","year":"2020","unstructured":"George SL, Parmar V, Lorenzi F, Marshall LV, Jamin Y, Poon E, Angelini P, Chesler L. Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma. J Exp Clin Cancer Res. 2020;39(1):78.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"2526_CR39","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1158\/0008-5472.CAN-21-2997","volume":"82","author":"Z Wilson","year":"2022","unstructured":"Wilson Z, Odedra R, Wallez Y, Wijnhoven P, Hughes A, Gerrard J, Jones G, Bargh-Dawson H, Brown E, Young L, et al. ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a Monotherapy and in Combination with Chemotherapy and the PARP Inhibitor Olaparib. Cancer Res. 2022;82(6):1140\u201352.","journal-title":"Cancer Res"},{"issue":"2","key":"2526_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.annonc.2021.10.009","volume":"33","author":"R Kim","year":"2022","unstructured":"Kim R, Kwon M, An M, Kim S, Smith S, Loemb\u00e9 A, Mortimer P, Armenia J, Lukashchuk N, Shah N, et al. Ann Oncol. 2022;33(2):193\u2013203.","journal-title":"Ann Oncol"},{"issue":"11","key":"2526_CR41","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1038\/s41418-020-0558-4","volume":"27","author":"H Yu","year":"2020","unstructured":"Yu H, Ding J, Zhu H, Jing Y, Zhou H, Tian H, Tang K, Wang G, Wang X. LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2. Cell Death Differ. 2020;27(11):3021\u201336.","journal-title":"Cell Death Differ"},{"key":"2526_CR42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.redox.2013.12.020","volume":"2","author":"B Gyori","year":"2014","unstructured":"Gyori B, Venkatachalam G, Thiagarajan P, Hsu D, Clement M. OpenComet: an automated tool for comet assay image analysis. Redox Biol. 2014;2:457\u201365.","journal-title":"Redox Biol"},{"issue":"10","key":"2526_CR43","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1038\/bjc.2014.162","volume":"110","author":"S Han","year":"2014","unstructured":"Han S, Zhang C, Li Q, Dong J, Liu Y, Huang Y, Jiang T, Wu A. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma. Br J Cancer. 2014;110(10):2560\u20138.","journal-title":"Br J Cancer"},{"key":"2526_CR44","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman E, Lightfoot H, Forbes S, Bindal N, Beare D, Smith J, Thompson I, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41:D955-961.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2526_CR45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ccr.2010.08.011","volume":"18","author":"S Mir","year":"2010","unstructured":"Mir S, De Witt Hamer P, Krawczyk P, Balaj L, Claes A, Niers J, Van Tilborg A, Zwinderman A, Geerts D, Kaspers G, et al. In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. Cancer Cell. 2010;18(3):244\u201357.","journal-title":"Cancer Cell"},{"issue":"5","key":"2526_CR46","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.celrep.2019.09.069","volume":"29","author":"D Li","year":"2019","unstructured":"Li D, Wu R, Guo W, Xie L, Qiao Z, Chen S, Zhu J, Huang C, Huang J, Chen B, et al. STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. Cell Rep. 2019;29(5):1249-1260.e1244.","journal-title":"Cell Rep"},{"issue":"5","key":"2526_CR47","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.molcel.2018.07.034","volume":"71","author":"G Dunphy","year":"2018","unstructured":"Dunphy G, Flannery S, Almine J, Connolly D, Paulus C, J\u00f8nsson K, Jakobsen M, Nevels M, Bowie A, Unterholzner L. Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-\u03baB Signaling after Nuclear DNA Damage. Mol Cell. 2018;71(5):745-760.e745.","journal-title":"Mol Cell"},{"key":"2526_CR48","doi-asserted-by":"publisher","first-page":"114082","DOI":"10.1016\/j.addr.2021.114082","volume":"181","author":"A Guha","year":"2022","unstructured":"Guha A, Waris S, Nabors L, Filippova N, Gorospe M, Kwan T, King P. The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack. Adv Drug Deliv Rev. 2022;181:114082.","journal-title":"Adv Drug Deliv Rev"},{"issue":"35","key":"2526_CR49","doi-asserted-by":"publisher","first-page":"17261","DOI":"10.1073\/pnas.1905172116","volume":"116","author":"S Mubaid","year":"2019","unstructured":"Mubaid S, Ma J, Omer A, Ashour K, Lian X, Sanchez B, Robinson S, Cammas A, Dormoy-Raclet V, Di Marco S, et al. HuR counteracts miR-330 to promote STAT3 translation during inflammation-induced muscle wasting. Proc Natl Acad Sci U S A. 2019;116(35):17261\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2526_CR50","doi-asserted-by":"publisher","first-page":"188614","DOI":"10.1016\/j.bbcan.2021.188614","volume":"1876","author":"E Grillo","year":"2021","unstructured":"Grillo E, Ravelli C, Corsini M, Zammataro L, Mitola S. Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants. Biochim Biophys Acta Rev Cancer. 2021;1876(2):188614.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"8","key":"2526_CR51","doi-asserted-by":"publisher","first-page":"737","DOI":"10.4161\/cbt.10.8.13417","volume":"10","author":"D Shi","year":"2010","unstructured":"Shi D, Grossman S. Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets. Cancer Biol Ther. 2010;10(8):737\u201347.","journal-title":"Cancer Biol Ther"},{"issue":"15","key":"2526_CR52","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.7150\/ijbs.50074","volume":"16","author":"Y Song","year":"2020","unstructured":"Song Y, Wu X, Xu Y, Zhu J, Li J, Zou Z, Chen L, Zhang B, Hua C, Rui H, et al. HPV E7 inhibits cell pyroptosis by promoting TRIM21-mediated degradation and ubiquitination of the IFI16 inflammasome. Int J Biol Sci. 2020;16(15):2924\u201337.","journal-title":"Int J Biol Sci"},{"key":"2526_CR53","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.isci.2019.05.002","volume":"15","author":"A Guha","year":"2019","unstructured":"Guha A, Ahuja D, Das Mandal S, Parasar B, Deyasi K, Roy D, Sharma V, Willard B, Ghosh A, Ray PS. Integrated Regulation of HuR by Translation Repression and Protein Degradation Determines Pulsatile Expression of p53 Under DNA Damage. iScience. 2019;15:342\u201359.","journal-title":"iScience"},{"issue":"22","key":"2526_CR54","doi-asserted-by":"publisher","first-page":"9889","DOI":"10.1021\/acs.jmedchem.8b01187","volume":"61","author":"K Foote","year":"2018","unstructured":"Foote K, Nissink J, McGuire T, Turner P, Guichard S, Yates J, Lau A, Blades K, Heathcote D, Odedra R, et al. Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Kinase with Application as an Anticancer Agent. J Med Chem. 2018;61(22):9889\u2013907.","journal-title":"J Med Chem"},{"issue":"1","key":"2526_CR55","doi-asserted-by":"publisher","first-page":"e000340","DOI":"10.1136\/jitc-2019-000340","volume":"8","author":"H Sheng","year":"2020","unstructured":"Sheng H, Huang Y, Xiao Y, Zhu Z, Shen M, Zhou P, Guo Z, Wang J, Wang H, Dai W, et al. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma. J Immunother Cancer. 2020;8(1):e000340.","journal-title":"J Immunother Cancer"},{"issue":"17","key":"2526_CR56","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1158\/1078-0432.CCR-21-0251","volume":"27","author":"S Kim","year":"2021","unstructured":"Kim S, Smith S, Mortimer P, Loemb\u00e9 A, Cho H, Kim K, Smith C, Willis S, Irurzun-Arana I, Berges A, et al. Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer. Clin Cancer Res. 2021;27(17):4700\u20139.","journal-title":"Clin Cancer Res"},{"issue":"17","key":"2526_CR57","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1158\/1078-0432.CCR-21-1778","volume":"27","author":"A Ashworth","year":"2021","unstructured":"Ashworth A. ATR Inhibitors and Paclitaxel in Melanoma. Clin Cancer Res. 2021;27(17):4667\u20138.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2526_CR58","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1172\/JCI131180","volume":"130","author":"C Orvain","year":"2020","unstructured":"Orvain C, Lin Y, Jean-Louis F, Hocini H, Hersant B, Bennasser Y, Ortonne N, Hotz C, Wolkenstein P, Boniotto M, et al. Hair follicle stem cell replication stress drives IFI16\/STING-dependent inflammation in hidradenitis suppurativa. J Clin Invest. 2020;130(7):3777\u201390.","journal-title":"J Clin Invest"},{"key":"2526_CR59","doi-asserted-by":"publisher","first-page":"981487","DOI":"10.4061\/2010\/981487","volume":"2010","author":"HH Kim","year":"2010","unstructured":"Kim HH, Abdelmohsen K, Gorospe M. Regulation of HuR by DNA Damage Response Kinases. J Nucleic Acids. 2010;2010:981487.","journal-title":"J Nucleic Acids"},{"issue":"4","key":"2526_CR60","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41419-021-03664-1","volume":"12","author":"J Xu","year":"2021","unstructured":"Xu J, Zhang J, Zhang Z, Gao Z, Qi Y, Qiu W, Pan Z, Guo Q, Li B, Zhao S, et al. Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction. Cell Death Dis. 2021;12(4):373.","journal-title":"Cell Death Dis"},{"key":"2526_CR61","doi-asserted-by":"crossref","unstructured":"Almine J, O\u2019Hare C, Dunphy G, Haga I, Naik R, Atrih A, Connolly D, Taylor J, Kelsall I, Bowie A, et al. IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes. Nat Commun. 2017;8:14392.","DOI":"10.1038\/ncomms14392"},{"issue":"6","key":"2526_CR62","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11427-016-9058-6","volume":"60","author":"S Li","year":"2017","unstructured":"Li S, Bao X, Wang D, You L, Li X, Yang H, Bian J, Wang Y, Yang Y. APOBEC3B and IL-6 form a positive feedback loop in hepatocellular carcinoma cells. Sci China Life Sci. 2017;60(6):617\u201326.","journal-title":"Sci China Life Sci"},{"issue":"9","key":"2526_CR63","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41568-018-0034-3","volume":"18","author":"E Lecona","year":"2018","unstructured":"Lecona E, Fernandez-Capetillo O. Targeting ATR in cancer. Nat Rev Cancer. 2018;18(9):586\u201395.","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02526-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-022-02526-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02526-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T22:05:53Z","timestamp":1668722753000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-022-02526-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2526"],"URL":"https:\/\/doi.org\/10.1186\/s13046-022-02526-8","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"4 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was authorized by the Ethics Committee of Qilu Hospital. The animal experiments in this study were approved by the Ethics Committee of Qilu Hospital (No. DWLL-2021\u2013082).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for the publication of the manuscript in Journal of Experimental & Clinical Cancer Research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}